Mar­ket crash slumps biotech as in­vestors yank $1.2B from funds

Af­ter soar­ing 11% on the highs of JPM hype and mega-sized merg­ers and ac­qui­si­tions, the Nas­daq Biotech In­dex is tum­bling in Feb­ru­ary.

That rapid down­shift is tied to in­vestors pulling $1.2 bil­lion out of health care and biotech funds last week, bring­ing the NBI down 8.2% since the start of the month.

A Thurs­day night spe­cial. For the week end­ed Feb­ru­ary 7, biotech had net out­flows of $1.21B. (Piper) pic.twit­ter.com/VvO0OmsmKL

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER